New Drug May Relieve Heartburn in Patients With Refractory Reflux Disease

Reuters Health Information
25 Mar, 2020 ,

According to results from a randomized clinical trial, IW-3718 reduces heartburn symptoms in patients with refractory gastroesophageal reflux disease. IW-3718 is an investigational bile acid sequestrant. Patients treated with IW-3718 1,500 mg experienced numerically greater improvements for all 10 individual symptoms assessed on the Modified Reflux Symptom Questionnaire-Electronic Diary.